Home
About Us
Browse Journals
Sitemap
Contact Us
Clinical Oncology: Case Reports
Toggle navigation
Editorial Board
Instructions
For Author
Policies & Ethics
Aim & Scope
Peer Review
Membership Program
Subscription
Submit Manuscript
Articles
Articles In Process
View All Issues
Special Issue
Introduction
Guidelines
Call For Papers
Citations
Contact
All submissions of the EM system will be redirected to
Online Manuscript Submission System
. Authors are requested to submit articles directly to
Online Manuscript Submission System
of respective journal.
About Cancer Epidemiology
High Impact List of Articles
Loading...
Explore SciTechnol
Author Guidelines
Reviewer Guidelines
Hybrid Model
Associations
Submit Manuscript
Conferences
eBooks
Relavant Topics
Anti-Cancer Drug
Breast Cancer
COVID-19 Convalescent Plasma
Cancer
Cancer Epidemiology
Cancer Gene Therapy
Cancer Treatment
CancerTherapy
Carbon nanotubes
Carcinogenesis
Carcinoma Case Reports
Cellular Oncology
Chemotherapy
Colorectal Cancer
Gastrointestinal Oncology
Graphene
Green Nanotechnology
Hormone Therapy
Immune Checkpoint Inhibitor
Immunotherapies
Immunotherapy
Liver Oncology
Lymphoma
Molecular nanotechnology
Nanobiotechnology
Nanodevices
Nanoelectronics
Nanoethics
Nanofabrication
Nanolithography
Nanomaterials
Nanoparticle
Nanorobotics
Nanosensors
Nanotechnology
Nanotoxicology
Neoplasm
Neuro oncology
Pancreatic Cancer
Polymer Nanotechnology
Precision Medicine
Quantum Dots
Radiation Therapy Case Reports
Radiation oncology
Radiotherapy
Stem cell transplants
Surgical oncology
Targeted therapy
Tumor Immunity
Tumor therapy
Recommended Journals
Journal of Nanomaterials and Molecular Nanotechnology
Clinical Oncology: Case Reports
PMC/PubMed Indexed Articles
Mycophenolate as Primary Treatment for Immune Checkpoint Inhibitor Induced Acute Kidney Injury in a Patient with Concurrent Immunotherapy-Associated Diabetes: A Case Report
Elective Colectomy in A Patient with Active Ulcerative Colitis and Metastatic Melanoma Enabling Successful Treatment with Immune Checkpoint Inhibitors
View More »
Tweets by @
GET THE APP